Neutropenia poses significant challenges for patients, impacting their immune response and overall health.
The efforts of the EuNet-INNOCHRON network, as highlighted in this post by COST, have brought vital advancements in the recognition, diagnosis, and treatment of this condition.
We are inspired by the dedicated work of experts like Prof. Helen Papadaki, whose insights help shine a light on this progress and its global impact. We extend our gratitude to everyone who contributed to this impactful initiative, including all EuNet-INNOCHRON members, for making these advancements possible.
Professor Helen Papadaki of the University of Crete, Chair of the Action, gives an overview of neutropenia, the Action’s efforts to prevent its progression to acute leukaemia, and the new areas of research that have emerged in this field.
🔗 Read more about these crucial developments and the strides being made for neutropenia patients: https://www.cost.eu/advancing-neutropenia-research/
Our EuNet-INNOCHRON Action (European Network for Innovative Research and Clinical Care in Chronic Neutropenias) is dedicated to enhancing knowledge, diagnosis, and treatment of chronic neutropenias. By connecting experts, researchers, and healthcare professionals across Europe, our network fosters collaboration and promotes innovative approaches to improve patient care.